MacroGenics
MGNX
#8690
Rank
A$0.37 B
Marketcap
A$5.81
Share price
0.24%
Change (1 day)
136.71%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.37 Billion

As of September 2026 MacroGenics has a market cap of A$0.37 Billion. This makes MacroGenics the world's 8690th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.37 B143.54%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Sep 19th, 2026 the market cap of MacroGenics was reported to be:

A$0.37 Billion
by Nasdaq info icon info icon
A$0.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$221.37 B 59,680.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.443 T 389,752.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$292.76 B 78,959.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$261.36 B 70,478.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$508.81 B 137,301.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$180.88 B 48,745.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$2.58 B 596.96%๐Ÿ‡บ๐Ÿ‡ธ USA